INTRODUCTION
N-Acetylgalactosamine 6-sulphatase (G6S) is one of the lysosomal enzymes involved in the degradation of the glycosaminoglycans keratan sulphate (KS) and chondroitin 6-sulphate (C6S). It catalyses the hydrolysis of the 6-sulphate ester bond present at the non-reducing terminus of C6S oligosaccharides, namely N-acetylgalactosamine 6-sulphate, and it also acts on galactose 6-sulphate linkages in KS. The deficiency ofthis enzyme activity results in the lysosomal storage disorder mucopolysaccharidosis type IVA (Morquio syndrome A), which is inherited as an autosomal recessive trait. The clinical presentation of this disorder is characterized by normal intelligence, dwarfism, corneal clouding, spondyloepiphysial dysplasia and dental abnormalities (Neufeld & Muenzer, 1989) . There is storage of partially degraded KS and C6S fragments in tissues as well as excessive urinary excretion of these fragments. As with the other mucopolysaccharidosis disorders, phenotypic variability exists, consistent with the occurrence of different mutant alleles at the G6S locus. Attempts to purify this enzyme from human tissues have been only partially successful. Human placental G6S has been purified about 20000-fold to approx. 70% purity (Gl6ssl et al., 1979) and to 3000-fold (Lim & Horwitz, 1981) . In the present paper we report the purification of human liver G6S to more than 130000-fold and some of its physical and kinetic properties.
MATERIALS
Human livers were obtained from autopsies of normal adults with times post mortem ranging from 6 to 72 h and were stored at -20 C.
Concanavalin A-Sepharose 4B (800 mg of lectin/100 ml of gel), PBE94 chromatofocusing medium, phenyl-Sepharose CL-4B, Polybuffer 74, chelating Sepharose 6B and the molecular-mass standard kits for SDS/PAGE gel chromatography were obtained from Pharmacia Fine Chemicals (Uppsala, Sweden). E. Merck (Darmstadt, Germany) supplied TSK HW5OS Fractogel, and LKB (Bromma, Sweden) supplied TSK G3000SW Ultrapac. Blue A Matrix agarose gel, the DC-2 hollow-fibre concentrator having 10 kDa-cut-off hollow fibres, the ultrafiltration stirred cells (model 8200) and the Diaflo ultrafiltration membrane YM 10 were obtained from Amicon (Danvers, MA, U.S.A.). Protein assay reagent was obtained from Bio-Rad Laboratories (Richmond, CA, U.S.A.) . Dialysis membrane with a 10-12 kDa cutoff was obtained from Union Carbide Corp. (Chicago, IL, U.S.A.). BSA (crystalline grade) was obtained from Sigma Chemical Co. (St. Louis, MO, U.S.A.).
METHODS
Assay of G6S activity G6S activity was assayed under identical conditions with either the trisaccharide substrate (Ga1NAc6S-GlcAGalitolNAc6S) derived from C6S or the disaccharide substrate (Gal6S-anM6S) prepared from KS (Hopwood & Elliott, 1983a,b) . The total assay volume of 12 ,ul included 1 gl, equivalent to 200 /SM, of either of the above substrates (specific radioactivity 427 c.p.m./pmol and 775 c.p.m./pmol respectively), 3 1tl of0.2 Msodium acetate buffer, pH 3.8, containing 2 mg of BSA/ml, 3 ,1 of 27 mM-2-acetamido-2-deoxy-D-gluconolactone, 4,1 of water and 1 #u1 of enzyme sample either diluted in 50 mM-sodium acetate buffer, pH 4.0, or dialysed against 50 mM-sodium acetate buffer, pH 4.0, containing 10% (v/v) glycerol and 0.1 mmdithioerythritol. 2-Acetamido-2-deoxy-D-gluconolactone, which is an inhibitor of f6-hexosaminidase, was omitted in the kinetic Vol. 279 Abbreviations used: G6S, N-acetylgalactosamine 6-sulphatase; KS, keratan sulphate; C6S, chondroitin 6-sulphate; GalNAc6S-GlcA-GalitolNAc6S, N-acetylgalactosamine 6-sulphate-glucuronic acid-N-acetylgalactosaminitol 6-sulphate; Gal6S-anM6S, galactose 6-sulphate-anhydromannitol 6-sulphate.
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studies with 'pure' enzyme. Assay tubes were incubated at 37 IC for 1 h with the C6S-derived trisaccharide substrate or for 5-8 h with the KS-derived disaccharide substrate to give less than 30 % breakdown of substrate to product. The reaction was stopped by freezing the assay mixture, and the substrate and product were separated by using high-voltage electrophoresis according to a previously described method . Enzyme activity was determined from percentage breakdown of each substrate to product and was expressed as pmol of product/min per ,ul. Assay of other lysosomal enzyme activities a-L-Iduronidase, with the fluorogenic substrate 4-methylumbelliferyl x-L-iduronide (Clements et al., 1985b) , glucosamine 6-sulphatase (Freeman et al., 1987) , N-acetylgalactosamine 4-sulphatase and iduronate 2-sulphatase were assayed by previously reported procedures. ,-Hexosaminidase activity towards GalNAc-GlcAGalitolNAc6S was determined in the absence of 2-acetamido-2-deoxy-D-gluconolactone . Arylsulphatase activity was measured at pH 5.7 against 4-methylumbelliferyl sulphate (Chang et al., 1981) .
Purification of G6S
All procedures were carried out at 4°C unless otherwise stated.
Step 1: lver extraction. Approx. 900 g of liver was homogenized in 3 vol. of 15 mM-sodium dimethylglutarate buffer, pH 6.0, containing 0.5 M-NaCl and 0.1 mM-dithioerythritol (buffer A), delipidated with carbon tetrachloride and centrifuged further at 27000 g for 30 min (Clements et al., 1983; Mahuran et al., 1983a) .
Step 2: concanavalin A-Sepharose -Blue A-agarose chromatography. The step 1 clear supernatant (1.5-2 litres) was applied to a 300 ml concanavalin A-Sepharose column equilibrated in buffer A containing 1 mM-MnCl2 and 1 mM-CaC12 and washed extensively with 6 litres of buffer A. The enzyme was eluted from concanavalin A-Sepharose according to a method described elsewhere (Mahuran et al., 1983a; Clements et al., 1983) . Unbound proteins were displaced with 2 litres of buffer A, and this fraction (2-2.5 litres), from now on referred to as the concanavalin A recycling eluate (CARE), was concentrated to 250-300 ml on a Amicon hollow-fibre concentrator. Six such CARE fractions were combined and concentrated to 84 ml in an Amicon stirred cell and then dialysed for 16 h against 5 litres of 30 mM-Tris/HCI buffer, pH 7.2, containing 10 % (v/v) glycerol, 0.1 mM-dithioerythritol and 3 mM-NaN3 (buffer B). No significant loss of enzyme activity occurred from this processing and subsequent centrifugation in step 3.
Step 3: chromatofocusing chromatography (Fig. 1) . The dialysed fraction from step 2 was centrifuged at 1800 g for 10 min, and the supernatant was loaded on to a PBE94 column (45 cm x 1.5 cm) equilibrated in buffer B (flow rate 1 ml/min) and washed with 200-300 ml of buffer B until absorption at 280 nm approached baseline level. Bound proteins were eluted with 1 litre of Polybuffer 74 that had been diluted 1 in 18 in water, the pH was adjusted to 4.0 with HCI and the solution was made 10% (v/v) in glycerol, 0.1 mM in dithioerythritol and 3 mM in NaN3 (buffer C). The column was then eluted with 300 ml of buffer C containing 0.25 M-NaCl. Fractions containing G6S were pooled as shown in Fig. 1 .
Step 4: TSK HW50S Fractogel chromatography. The A pool of fractions from step 3 was concentrated to 2.0 ml in an Amicon ultrafiltration stirred cell and the buffer was changed to 15 mMsodium dimethylglutarate buffer, pH 6.0, containing 0.5 M-NaCl, 10% (v/v) glycerol, 0.1 mM-dithioerythritol and 3 mM-NaN3
(buffer D). The sample was loaded on to the TSK HW5OS Fractogel column (110 cm x 2.5 cm) and eluted with buffer D with a flow rate of 0.5 ml/min. G6S active fractions were pooled, the pH was adjusted to pH 6.5 with 0.1 M-NaOH and the preparation was applied to the next column.
Step 5: Cu21-chelation Sepharose chromatography (Fig. 2 ). This column (3 cm x 1 cm) was saturated with copper acetate and equilibrated in buffer D minus dithioerythritol. The sample from step 4 was loaded, washed on with the above buffer and eluted with a decreasing linear pH gradient made from two solutions of buffer D, one of which was at pH 6.5, the other at pH 3.5. Fractions containing enzyme activity were pooled as shown in Fig. 2 .
Step 6: phenyl-Sepharose CL-4B chromatography. This hydrophobic column (3 cm x 1 cm) was equilibrated in buffer D and run at room temperature (20-25 '). The sample from step 5 was concentrated to 13 ml, the buffer was changed to buffer D, and it was loaded and washed on with three 10 ml portions of buffer D. The column was eluted with three 10 ml portions of buffer D (without glycerol) for each concentration of ethylene glycol starting at 20 % (v/v) and increasing to 25 %, 30 %, 35 %, 40 %, 45 % and 50 % (v/v). The eluate was collected into tubes standing in ice. Both the flow-through and the first 20 %-(v/v)-ethylene glycol wash, which contained enzyme activity, were pooled and concentrated to 1.0 ml.
Step 7: TSK G3000SW Ultrapac chromatography (Fig. 3 ). The concentrated sample was applied at room temperature to an LKB Ultrachrom GTi f.p.l.c. system with a TSK G3000SW Ultrapac column (30 cm x 0.8 cm), equilibrated and eluted in buffer D at flow rate of 0.5 ml/min and pressure of 150 kPa. A 100 lO sample of each fraction from 18 to 26 was separately treated with deoxycholate/trichloroacetic acid for SDS/PAGE. The remainder of each fraction showing G6S was pooled as shown in Fig. 3 and loaded directly on to the next column.
Step 8: second Cu21-chelation Sepharose chromatography (Fig.  4) . A column (1 cm x 1 cm) was saturated with copper acetate and equilibrated in buffer D without dithioerythritol. The enzyme sample was applied, washed with 20 ml of the above buffer and then eluted with 1O ml volumes of the same buffer, but at decreasing pH, starting at pH 4.6, then pH 4.0 and finally pH 3.5. Fractions (2 ml) were collected, and those containing enzyme activity were pooled as shown in Fig. 4 SDS/PAGE Samples for electrophoresis were prepared by precipitation with deoxycholate/trichloroacetic acid, as described by Mahuran et al. (1983b) . Discontinuous SDS/polyacrylamide slab gels with 12% acrylamide were run according to the method of Laemmli (1970) . All samples were denatured before electrophoresis by incubation for 2 min at 100°C in the presence or in the absence (where indicated) of 0.1 mM-dithioerythritol. Gels were stained with Coomassie Brilliant Blue R250. Pharmacia molecular-mass standards were used for gel calibration and included the following proteins: phosphorylase b (94 kDa), BSA (67 kDa), ovalbumin (43 kDa), carbonic anhydrase (30 kDa), soya-bean trypsin inhibitor (20.1 kDa) and a-lactalbumin (14.4 kDa).
Kinetic experiments
Enzyme solution containing 500 jig of BSA/ml was dialysed overnight at 4°C against 2 litres of 50 mM-sodium acetate buffer, pH 4.0, containing 10 % (v/v) glycerol, 0.1 mM-dithioerythritol and 3 mM-NaN3. The pH-activity profiles were obtained with a 12 ,ul assay containing substrate and 50 mM-sodium acetate or 50 mM-sodium formate buffer (pH as indicated). Reactions were initiated by the addition of 1 jul of dialysed enzyme (equivalent to 1.25 ng to 15 ng of G6S protein) and incubated at 37°C. Incubation times were optimized to give a percentage breakdown of substrate to product in the range 5-30%, which was linear with respect to time. Reactions were terminated by plunging the reaction tubes into an ethanol/solid CO2 bath. The substrate and product were separated according to the procedure described above under 'Assay of G6S activity'.
Kinetic data (Km and Vm.ax) were obtained with assay conditions similar to those for the pH-activity profiles. Substrate concentrations ranged from 2 to 42 4M. Incubation time was adjusted to within the linear range for substrate hydrolysis. Incubations were at the optimum pH for both substrates. Km and VM,X values were obtained from Lineweaver-Burk plots.
RESULTS

Purification of G6S
Extraction from human liver and application to the coupled concanavalin A-Sepharose -Blue A-agarose columns was according to the protocol already existing in this laboratory for the extraction of other lysosomal enzymes and not optimal for this enzyme (Mahuran et al., 1983a; Clements et al., 1985a; Freeman & Hopwood, 1986 , 1989 Freeman et al., 1987; Gibson et al., 1987; Bielicki et al., 1990) . Approx. 98 % of the G6S activity was bound to concanavalin A-Sepharose, and 86 % in the step 1 high-speed supernatant was recovered in the CARE fraction and 5.0% was eluted from the Blue A-agarose (Table 1) chromatofocusing medium PBE94 was complete, and most of the bound enzyme was eluted with Polybuffer 74 between pH 5.4 and pH 6.0. The low recovery of enzyme activity (29 %) from this step may reflect the instability of the enzyme at pH 6.0 in low-ionic-strength buffer, or aggregation at its pl in low-ionicstrength buffer. A second form of G6S was eluted at pH 5.4, and a third form that was more tightly bound required pH 4.0 and 0.25 M-NaCl for elution (Fig. 1 ). These two forms accounted for less than 6% of the total G6S activity loaded and were not further characterized. Although enzyme recovery was somewhat Column void volume (V1) is arrowed. The insert shows SDS/PAGE of fractions 18-26 as shown in lanes 1-9, which correspond to the elution volumes 9.0 ml, 9.5 ml, 10.0 ml etc. to 13.0 ml. All samples were reduced with dithioerythritol and stained with Coomassie Brilliant Blue. Positions of molecular-mass standards are arrowed. poor this step was valuable in removing a large proportion of contaminating proteins (72 %), among which were the lysosomal enzymes iduronate 2-sulphatase, a-L-iduronidase and glucosamine 6-sulphatase, of which 90 % or more was removed. The next step, TSK HW50S chromatography, removed 90% contaminating protein and was necessary for the removal from the enzyme solution of Polybuffer 74, which, if present, interfered with the subsequent Cu2+-chelation Sepharose chromatography step by removing the bound Cu2+. The apparent native molecular mass of G6S was estimated from molecular-mass calibration data to be 64 kDa. Adjusting the pH of the pooled fractions from step 4 to pH 6.5 with 0.1 M-NaOH resulted in no loss of activity. Recovery of activity from the step 5 Cu21-chelation Sepharose was approx. 50 % of the enzyme loaded with 82 % removal of protein (Table 1) . Elution of G6S activity from this column commenced at pH 4.2, with all activity completely eluted by pH 3.5. Elution of arylsulphatase activity commenced at pH 3.8 and required a longer elution time at pH 3.5 for complete elution (Fig. 2) . Under the conditions used in the hydrophobic step 6, G6S did not bind to phenyl-Sepharose CL-4B and consequently this step only removed 39 % contaminants. Another estimate of native molecular mass was obtained for G6S eluted from the step 7 f.p.l.c. as being 62 kDa. SDS/PAGE of a sample from each fraction (18-26) across the f.p.l.c. profile (see Fig. 3 inset) run under reducing conditions indicated that the polypeptides most likely to be part of G6S were those at 57 kDa, 39 kDa or 19 kDa, or, in fact, all three may be involved. The few contaminants present on the SDS/PAGE were between 30 kDa and 25 kDa. The bulk of these was eliminated by selectively pooling fractions 21-23 from the f.p.l.c. step. Re-application of these fractions directly on to a small Cu2+-chelation Sepharose column and use of a 'batch' method for elution rather than a linear pH gradient were only marginally successful in removing the final contaminating proteins (see Fig. 4 inset) . SDS/PAGE of a sample from fractions 18-22 shows the contaminants between 30 kDa and 25 kDa. SDS/PAGE under non-reducing conditions of fraction 19, the fraction having highest activity on the second Cu2+-chelation Sepharose step, resulted in the appearance of a major band at 70 kDa, a less intense band at 60 kDa and two faint bands at 50 kDa and 39 kDa (Fig. 4) . The result of this eight-step purification procedure was that G6S was purified 130 700-fold in 2.8 % yield of activity, which is equivalent to approx. 60 ,ug of protein from 5.4 kg of liver. Iduronate 2-sulphatase, glucosamine 6-sulphatase, fl-hexosaminidase, N-acetylgalactosamine 4-sulphatase, az-L-iduronidase and arylsulphatase activities were not detected in fraction 19 (Fig. 4) .
Properties of G6S
Enzyme in fraction 19 from the second Cu2+-chelation Sepharose column was dialysed with 0.5 mg of BSA/ml against 0.05 M-sodium acetate buffer, pH 4.0, containing 10% (v/v) glycerol and 0.1 mM-dithioerythritol. This dialysed sample was used for determination of kinetic data as well as some physical
properties of the enzyme. The pH optimum for G6S activity towards C6S and KS oligosaccharide substrates was between .0-x pH 3.5 and pH 4.0 (Fig. 5 ). The Km with the KS-derived disaccharide substrate at the pH optimum was 50/tm and the .5- 50 % inhibition at 20 mm-and 24 mM-NaCl respectively (Fig. 6 ). . Hydrolysis of GalNAc6S-GlcA-GalitolNAc6S by liver G6S as a function of NaCl (A), Na2HPO4 (0) and Na2SO4 (0) concentration and of G6S-anM6S by G6S as a function of NaCl (rO) concentration at pH 4.0 in 50 mM-sodium acetate buffer containing 500 ug of BSA/ml For experimental details see the Methods section.
DISCUSSION
We have purified, by an eight-step column procedure, G6S from human liver by more than 130000-fold with a recovery of 2.8 % activity of one major form. The procedure has the advantage that other lysosomal enzymes involved in glycosaminoglycan degradation can be conveniently obtained from the same liver (Mahuran et al., 1983a; Clements et al., 1985a; Freeman & Hopwood, 1986 , 1989 Freeman et al., 1987; Gibson et al., 1987; Bielicki et al., 1990 ). An important purification step in the procedure was that of chromatography on TSK G3000SW, which led to a 15-fold purification of G6S with a native molecular mass of 62 kDa. This preparation contained 57 kDa, 39 kDa and 19 kDa polypeptide species on SDS/PAGE under reducing conditions. The N-terminal amino acid sequences obtained from the 39 kDa and 57 kDa polypeptides (results not shown) were the same and showed considerable similarity to the N-terminal amino acid sequences of other sulphatases Wilson et al., 1990; Peters et al., 1990) . The N-terminal amino acid sequence of the 19 kDa polypeptide (results not shown) showed some similarity to amino acid sequence found towards the C-terminal in the sulphatase family (Wilson et al., 1990; Peters et al., 1990) . As judged from yields of amino acids obtained during N-terminal sequencing, the 39 kDa and 19 kDa polypeptides were present in approximately equal amounts in the purified G6S from liver. These findings, together with the observation that the native molecular mass of unreduced G6S obtained by SDS/PAGE was 70 kDa (see discussion below) suggested that the 19 kDa and 39 kDa polypeptides are disulphide-linked to produce the 70 kDa component. Consistent but different multi-polypeptide band patterns are also observed for other lysosomal enzymes, namely a-L-iduronidase (Clements et al., 1989) and the sulphatases iduronate 2-sulphatase , glucosamine 6-sulphatase (Freeman et al., 1987) , glucuronate 2-sulphatase (Freeman & Hopwood, 1989) and N-acetylgalactosamine 4-sulphatase (Gibson et al., 1987) , purified to homogeneity from these same livers (Table 2 ). Of these, N-acetylgalactosamine 4-sulphatase and G6S are the only enzymes that have polypeptides linked by disulphide bonding. N-Acetylgalactosamine 4-sulphatase has 43 kDa and 8 kDa polypeptides that under non-reducing conditions yielded a single protein species with a molecular mass of 57 kDa on SDS/PAGE, whereas the molecular mass of the native protein assessed by gel-permeation chromatography was 43 kDa (Table  2 ). It appears that G6S has a similar pattern and relationship between reduced and non-reduced polypeptide molecular masses on SDS/PAGE and a smaller native molecular mass on gelpermeation chromatography. That is, the 19 kDa and 39 kDa polypeptides required to form active G6S in human liver appear to yield a protein with a native molecular mass determined by SDS/PAGE run under non-reducing conditions that is larger than the sum of the two polypeptides and that observed by gelpermeation chromatography.
Other investigators have reported purification of G6S from human placenta. Gl6ssl et al. (1979) described the isolation (20000-fold) ofthe enzyme in a 11 % yield with a native molecular mass of 100 kDa containing a single polypeptide of 78 kDa. However, the preparation was considered not to be pure since ,6-N-acetylhexosaminidase activity was detected and different polypeptide bands were observed on SDS/PAGE. Lim & Horwitz (198 1) reported that G6S purified (3000-fold) from human placenta with a 6 % recovery had a native molecular mass of 90 kDa and contained a single polypeptide of 85 kDa. It would therefore seem likely that both groups reporting purification of G6S from human placenta have not achieved purification to homogeneity.
Substrate structure has an important influence on the specificity of action and catalytic efficiency of sulphatases involved in the desulphation of glycosaminoglycan substrates in the lysosome (Hopwood, 1989) . Purified G6S is able to desulphate N-acetylgalactosamine 6-sulphate or galactose 6-sulphate residues derived from C6S and KS respectively. G6S is unable to desulphate glucosamine 6-sulphate residues in KS or heparan sulphate (results not shown). Thus G6S is specific for sulphate esters linked C-6 to hexose or N-acetylhexosamine with the galactose configuration. It also appears that purified G6S is approx. 60-70-fold more catalytically efficient at desulphating the C6S-derived trisaccharide than the disaccharide derived from KS. This difference in activity towards KS and C6S substrates was also observed for G6S present in crude fibroblast homogenates (Hopwood & Elliott, 1983a) , and is not likely to be explained by simply having decreased activity towards the disaccharide, since a tetrasaccharide substrate derived from KS is desulphated with similar activity to the disaccharide (Hopwood & Elliott, 1983b) .
